Your shopping cart is currently empty

FSG67 is a glycerol 3-phosphate acyltransferase (GPAT) and glycerol-3-phosphate acyltransferase, mitochondrial (GPAM) inhibitor that attenuates hepatic regeneration following acetaminophen overdose by altering GSK3β and Wnt/β-catenin signaling.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $147 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $322 | - | In Stock | |
| 25 mg | $438 | - | In Stock | |
| 50 mg | $572 | - | In Stock | |
| 100 mg | $745 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $272 | - | In Stock |
| Description | FSG67 is a glycerol 3-phosphate acyltransferase (GPAT) and glycerol-3-phosphate acyltransferase, mitochondrial (GPAM) inhibitor that attenuates hepatic regeneration following acetaminophen overdose by altering GSK3β and Wnt/β-catenin signaling. |
| Targets&IC50 | GPAT:24 μM, oxidative metabolis:27.7 μM |
| In vitro | FSG67 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor with an IC50 value of 24 μM.FSG67 was able to reduce the level of phosphorylation of GSK3β and associated signaling after paracetamol (acetaminophen) overdose. [1] In mature adipocytes, FSG67 elevated oxidative metabolism in a dose-dependent manner with an IC50 of 27.7 μM. [2] |
| Synonyms | FSG 67 |
| Molecular Weight | 327.44 |
| Formula | C16H25NO4S |
| Cas No. | 1158383-34-6 |
| Smiles | O=C(O)C=1C=CC=CC1NS(=O)(=O)CCCCCCCCC |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (244.32 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.08 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.